Navigation Links
Predicting chemotherapy outcome

Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy. In a study published today in the open access journal Genome Biology, researchers identified in the tumours of colorectal cancer patients almost 700 genes whose expression was different between patients who subsequently responded well to combined chemotherapy and patients who were resistant to the therapy. These findings could be used in clinical practice to complement clinical, biochemical and genetic markers for better treatment of patients with colorectal cancer.

A research group led by Sandrine Imbeaud from the CNRS and Pierre and Marie Curie University, Villejuif, France, used microarrays to analyse the gene-expression patterns of samples from colon tumours and liver metastases collected from 13 patients with colorectal cancer. The microarray analyses were carried out before the patients were treated with combined chemotherapy of folinic acid, 5-fluorouracil and irinotecan.

Imbeaud and colleagues identified 679 genes that were differently expressed in patients who subsequently responded well to chemotherapy compared with patients who were resistant to the therapy. The results were validated by RT-PCR analysis, which confirmed the differential expression of 22 genes selected from the list. The findings were also confirmed by RT-PCR analysis of colon and liver tumour samples collected from two additional patients.

The authors were able to integrate their findings into global and interconnected molecular networks that characterise resistance in patients with colorectal cancer before they are exposed to chemotherapy. They conclude that knowledge of these networks could potentially be used to improve diagnosis and treatment of patients with colorectal cancer.


'"/>

Source:BioMed Central


Page: 1

Related biology news :

1. Predicting success
2. Predicting successful outcomes in living-donor liver transplants
3. USC researchers determine mechanism of action of chemotherapy drug
4. Gene expression profile helps predict chemotherapy response in ovarian cancer patients
5. New device could cut chemotherapy deaths
6. Buckyballs boost antibodys chemotherapy payload
7. Injection may prevent infertility in men receiving cancer chemotherapy
8. First-ever genomic test predicts which lung cancer patients need chemotherapy to live
9. St. Jude finds clues to hearing loss from chemotherapy
10. Researchers examine why food tastes bad to chemotherapy recipients
11. Researchers urge monitoring of bone health during chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader of ... elite iris biometric solution on the latest Qualcomm® ... at Mobile World Congress 2017 (February 27 ... in Hall 3, Stand 3E10. ... Haven™ security platform—a combination of hardware, software ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... --  Boston Biomedical , an industry leader in the ... stemness pathways, today announced its Board of Directors has ... Officer, effective April 24, 2017. Ms. ... FACP, who has led Boston Biomedical since he founded ... Biomedical has grown from a "garage startup" without technology ...
(Date:3/22/2017)... Yorba Linda, Ca (PRWEB) , ... March 21, ... ... immunogenicity, and clearance of biologics. To acquire information on the desired increase and/or ... in the biopharmaceutical industry for rapid N-glycosylation profiling of therapeutic antibodies. , ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... has unveiled its innovative Quantum peristaltic pump with patented ReNu single-use (SU) ... the new standard for high-pressure feed pumps in SU tangential flow filtration ...
(Date:3/22/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... Chaim Lebovits , Chief Executive Officer, will provide an ... Sachs Associates 2 nd Annual Neuroscience Biopartnering and ... at the New York Academy of Sciences. ...
Breaking Biology Technology: